Somerset Indus Capital Partners 
Dealstreet

ELP advises Somerset Indus Capital Partners in its investment in Natural Biogenex

The investment amount remains undisclosed.

Bar & Bench

Somerset Indus Capital Partners has made an investment in Natural Biogenex Private Limited, a company manufacturing steroidal APIs.

This marks the fund’s sixth overall investment from its Fund II.

Economic Laws Practice advised Somerset Indus Capital Partners in this investment.

The transaction team consisted of Vinay Butani (Partner), Rudraksh Bhatt (Senior Associate) and Faiz Thakur (Senior Associate).

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi High Court restrains sale of merchandise infringing NTR Junior's personality rights

Chhattisgarh High Court grants bail to ex-CM's son Chaitanya Baghel in liquor scam

Kickstart your litigation career with Lis Peritus Certificate Course with real courtroom simulation

Khaitan, TT&A act on L Catterton's investment in Haldiram

CAM advises Zenrock Chemicals and EAAA India on acquiring promoter stake in Indo Borax & Chemicals

SCROLL FOR NEXT